Files
Download Full Text (779 KB)
Date
2016
Abstract
Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphine has been used as an office based treatment for addiction management. In Maine there is a provider shortage for substance abuse and a large need in the community for treatment. In fact there were 272 deaths in 2015 attributed to overdose. It is important that once patients begin treatment they remain in treatment without relapse. At EMMC Center for Family Medicine we explored risks for relapse from the provider perspective, patient perspective, and retrospective chart analysis in order to guide future interventions at this treatment program.
Clinical Site
EMMC Center for Family Medicine Bangor, Maine
Keywords
Maine, Relapse Risk, Opioid Addiction, Buprenorphine
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Disciplines
Medical Education | Primary Care
Recommended Citation
Carlson, Rachel E., "Understanding Opioid Addiction and Relpase Risks for Patients in an Office Based Buprenorphine Treatment Program" (2016). Family Medicine Clerkship Student Projects. 151.
https://scholarworks.uvm.edu/fmclerk/151